Published in Ann Intern Med on March 01, 1981
Diuresis or urinary alkalinisation for salicylate poisoning? Br Med J (Clin Res Ed) (1982) 2.90
Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure. J Clin Invest (1988) 1.15
Effects of non-narcotic analgesics on the kidney. Drugs (1986) 1.05
Non-steroidal Anti-inflammatory Drugs: Monitoring to help prevent serious adverse effects. Can Fam Physician (1991) 0.75
Which cyclosporin formulation? Lancet (1996) 3.34
Consensus statement on the live organ donor. JAMA (2000) 3.29
Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis (1996) 2.30
Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model. Transplantation (1996) 2.24
The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure. J Infect Dis (1979) 1.83
Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis (2000) 1.68
Cyst decompression surgery for autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1992) 1.68
Morphine and phenytoin binding to plasma proteins in renal and hepatic failure. Clin Pharmacol Ther (1975) 1.59
Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity. J Infect Dis (1989) 1.57
Renal manifestations of sarcoidosis. Arch Intern Med (1981) 1.47
Acute renal failure from ticrynafen. N Engl J Med (1979) 1.40
The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess. J Infect Dis (1988) 1.36
Action and toxicity of cyclosporine. Annu Rev Med (1986) 1.35
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care (2001) 1.32
Lead nephropathy. Kidney Int (1985) 1.24
The nephropathy of the nail-patella syndrome. Clinicopathologic analysis of 11 kindred. Am J Med (1973) 1.20
Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer. J Urol (2000) 1.15
Drug prescribing in renal failure: dosing guidelines for adults. Am J Kidney Dis (1983) 1.13
Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects. Clin Pharmacol Ther (1988) 1.12
Endogenous creatinine clearance as a clinical measure of glomerular filtration rate. Br Med J (1971) 1.12
Gentamicin and tobramycin nephrotoxicity. A morphologic and functional comparison in the rat. Am J Pathol (1978) 1.10
Drug-related syndromes in clinical nephrology. Ann Intern Med (1977) 1.10
Guidelines for drug therapy in renal failure. Ann Intern Med (1977) 1.10
Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol (1995) 1.09
Nephrotoxic acute renal failure due to common drugs. Am J Physiol (1981) 1.09
Renal function 27 years after unilateral nephrectomy for related donor kidney transplantation. J Urol (1988) 1.08
Attenuation of experimental tobramycin nephrotoxicity by ticarcillin. Antimicrob Agents Chemother (1985) 1.08
Phase I trial of pegylated interferon-alpha-2b in young patients with plexiform neurofibromas. Neurology (2011) 1.08
Cyclosporine nephrotoxicity. Ann Intern Med (1983) 1.07
Renal cholesterol accumulation: a durable response after acute and subacute renal insults. Am J Pathol (2001) 1.05
Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease. Am J Kidney Dis (1985) 1.04
Effect of sodium intake on gentamicin nephrotoxicity in the rat. Proc Soc Exp Biol Med (1976) 1.04
Reversibility of gentamicin nephrotoxicity in rats: recovery during continuous drug administration. Proc Soc Exp Biol Med (1979) 1.04
Role of splenectomy in renal transplantation. Urology (1973) 1.04
Drug dosing guidelines in patients with renal failure. West J Med (1992) 1.03
Trimethoprim-sulfamethoxazole in cyst fluid from autosomal dominant polycystic kidneys. Kidney Int (1987) 1.03
Ciprofloxacin activity in cyst fluid from polycystic kidneys. Antimicrob Agents Chemother (1988) 1.03
Djenkol bean poisoning (djenkolism): an unusual cause of acute renal failure. Am J Kidney Dis (1995) 1.02
Drug therapy in renal failure: dosing guidelines for adults. Part II: sedatives, hypnotics, and tranquilizers; cardiovascular, antihypertensive, and diuretic agents; miscellaneous agents. Ann Intern Med (1980) 1.02
Vascular mechanisms of cyclosporin-induced hypertension in the rat. J Clin Invest (1994) 1.01
Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation (1987) 1.01
A guide to drug therapy in renal failure. JAMA (1974) 1.01
High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience. Int J Radiat Oncol Biol Phys (1999) 1.01
Long-term protection of polyaspartic acid in experimental gentamicin nephrotoxicity. Antimicrob Agents Chemother (1991) 1.00
Ethylene glycol intoxication. Prevention of renal failure by aggressive management. JAMA (1973) 1.00
Macroscopic hematuria in mesangial IgA nephropathy: correlation with glomerular crescents and renal dysfunction. Kidney Int (1983) 1.00
Induction of contraction in isolated rat aorta by cyclosporine. Transplantation (1987) 1.00
Postrenal transplant erythrocytosis: a review of 53 patients. Kidney Int (1983) 0.99
Chronic cyclosporine nephrotoxicity. Curr Opin Nephrol Hypertens (1998) 0.99
The role of the pituitary-adrenal-thyroid axes in lung differentiation. I. Studies of the cytology and physical properties of anencephalic fetal rat lung. Lab Invest (1972) 0.98
Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines. Oncogene (2006) 0.98
Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int (1995) 0.98
Sex-related differences in the susceptibility of rats to gentamicin nephrotoxicity. J Infect Dis (1982) 0.97
Clinical characteristics and diagnostic considerations in acquired renal cystic disease. Kidney Int (1986) 0.97
Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal anti-inflammatory drugs as the sole or predominant analgesic. Am J Kidney Dis (1994) 0.97
Cyclosporine-associated hypertension. Am J Med (1988) 0.97
Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis. Kidney Int (1999) 0.97
SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Kidney Int (1996) 0.97
Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int (1998) 0.96
Analgesic nephropathy--a preventable renal disease. N Engl J Med (1989) 0.96
A practical guide to drug usage in adult patients with impaired renal function. JAMA (1970) 0.96
Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int (1996) 0.96
Herpes simplex type 1 hepatitis in renal transplantation. Arch Intern Med (1980) 0.95
Reduction of experimental gentamicin nephrotoxicity in rats by dietary calcium loading. Antimicrob Agents Chemother (1982) 0.95
Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy. Kidney Int (1996) 0.95
Gentamicin nephrotoxicity. I. Degree and permanence of acquired insensitivity. J Lab Clin Med (1982) 0.94
Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy. Kidney Int (1997) 0.93
Alterations in organic ion transport induced by gentamicin nephrotoxicity in the rat. J Lab Clin Med (1980) 0.92
Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: role of sodium intake. J Am Soc Nephrol (1993) 0.92
Guide to drug usage in adult patients with impaired renal function. A supplement. JAMA (1973) 0.92
Transient diabetes insipidus complicating systemic fat embolization. J Trauma (1972) 0.91
Renal transport of organic acids and bases in aminoglycoside nephrotoxicity. Antimicrob Agents Chemother (1979) 0.91
Partial lipodystrophy, C3 nephritic factor and clinically inapparent mesangiocapillary glomerulonephritis. Am J Med (1977) 0.91
Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity. Transplantation (1997) 0.91
Focal segmental glomerulosclerosis: a need for caution in live-related renal transplantation. Am J Kidney Dis (1999) 0.91
Comparative nephrotoxicities of high-dose netilmicin and tobramycin in rats. Antimicrob Agents Chemother (1980) 0.91
Drug therapy in renal failure: dosing guidelines for adults. Part I: Antimicrobial agents, analgesics. Ann Intern Med (1980) 0.90
Mechanism of fibrosis in experimental tacrolimus nephrotoxicity. Transplantation (1997) 0.90
Myeloid bodies in the renal tubules of humans: relationship to gentamicin therapy. Clin Nephrol (1978) 0.89
Urinary tract infections in patients with severe renal disease. Treatment with ampicillin and trimethoprim-sulfamethoxazole. JAMA (1976) 0.89
Flt-3 ligand (FL) drives differentiation of rat bone marrow-derived dendritic cells expressing OX62 and/or CD161 (NKR-P1). J Leukoc Biol (2002) 0.89
Effect of basis amino acids and aminoglycosides on 3H-gentamicin uptake in cortical slices of rat and human kidney. J Lab Clin Med (1982) 0.89
Pharmacodynamic model of topotecan-induced time course of neutropenia. Clin Cancer Res (2001) 0.89
Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity. Kidney Int (2000) 0.89
Reduction of cyst volume for symptomatic management of autosomal dominant polycystic kidney disease. J Urol (1987) 0.88
FK506 nephrotoxicity: morphologic and physiologic characterization of a rat model. Lab Invest (1995) 0.88
Achieving oral health in patients with renal failure and renal transplants. J Am Dent Assoc (1986) 0.88
Factors in cardiac risk stratification of candidates for renal transplant. J Cardiovasc Risk (1999) 0.88
Drug prescribing in renal failure. Drugs (1979) 0.88
"Dewlap". A corticosteroid-induced episternal fatty tumor. N Engl J Med (1966) 0.88
Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy. Kidney Int (1995) 0.88
Immunosuppressant-induced nephropathy: pathophysiology, incidence and management. Drug Saf (1999) 0.87
Effect of sodium bicarbonate and ammonium chloride ingestion in experimental gentamicin nephrotoxicity in rats. Res Commun Chem Pathol Pharmacol (1980) 0.87
Responsibilities of primary physicians in organ donation. Ann Intern Med (1987) 0.87
Response to dopamine hydrochloride in the hepatorenal syndrome. Arch Intern Med (1975) 0.86
Renal transplantation across the ABO barrier using A2 kidneys. Transplantation (1999) 0.86
Renal tubular acidosis. Arch Intern Med (1968) 0.86